Literature DB >> 32249846

Dysregulation of lung myeloid cells in COVID-19.

Bérengère Salomé1, Assaf Magen1.   

Abstract

Entities:  

Year:  2020        PMID： 32249846      PMCID： PMC7132548          DOI： 10.1038/s41577-020-0303-8

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN： 1474-1733            Impact factor:   53.106


× No keyword cloud information.
  11 in total

1.  COVID-19 Hyperinflammation: What about Neutrophils?

Authors:  Athanasios Didangelos
Journal:  mSphere       Date:  2020-06-24       Impact factor: 4.389

2.  The angiocrine Rspondin3 instructs interstitial macrophage transition via metabolic-epigenetic reprogramming and resolves inflammatory injury.

Authors:  Bisheng Zhou; Lissette Magana; Zhigang Hong; Long Shuang Huang; Sreeparna Chakraborty; Yoshikazu Tsukasaki; Cary Huang; Li Wang; Anke Di; Balaji Ganesh; Xiaopei Gao; Jalees Rehman; Asrar B Malik
Journal:  Nat Immunol       Date:  2020-08-24       Impact factor: 25.606

Review 3.  COVID-19: immunopathogenesis and Immunotherapeutics.

Authors:  Li Yang; Shasha Liu; Jinyan Liu; Zhixin Zhang; Xiaochun Wan; Bo Huang; Youhai Chen; Yi Zhang
Journal:  Signal Transduct Target Ther       Date:  2020-07-25

4.  Establishing a Unified COVID-19 "Immunome": Integrating Coronavirus Pathogenesis and Host Immunopathology.

Authors:  Els Wauters; Karin Thevissen; Carine Wouters; Francesca Maria Bosisio; Frederik De Smet; Jan Gunst; Stephanie Humblet-Baron; Diether Lambrechts; Adrian Liston; Patrick Matthys; Johan Neyts; Paul Proost; Birgit Weynand; Joost Wauters; Sabine Tejpar; Abhishek D Garg
Journal:  Front Immunol       Date:  2020-07-03       Impact factor: 7.561

5.  Nanocarrier vaccines for SARS-CoV-2.

Authors:  Jatin Machhi; Farah Shahjin; Srijanee Das; Milankumar Patel; Mai Mohamed Abdelmoaty; Jacob D Cohen; Preet Amol Singh; Ashish Baldi; Neha Bajwa; Raj Kumar; Lalit K Vora; Tapan A Patel; Maxim D Oleynikov; Dhruvkumar Soni; Pravin Yeapuri; Insiya Mukadam; Rajashree Chakraborty; Caroline G Saksena; Jonathan Herskovitz; Mahmudul Hasan; David Oupicky; Suvarthi Das; Ryan F Donnelly; Kenneth S Hettie; Linda Chang; Howard E Gendelman; Bhavesh D Kevadiya
Journal:  Adv Drug Deliv Rev       Date:  2021-01-09       Impact factor: 17.873

Review 6.  Risk factors for adverse outcomes of COVID-19 patients: Possible basis for diverse responses to the novel coronavirus SARS-CoV-2.

Authors:  Mahnaz Ghaebi; Safa Tahmasebi; Maryam Jozghorbani; Alireza Sadeghi; Lakshmi Thangavelu; Angelina Olegovna Zekiy; Abdolreza Esmaeilzadeh
Journal:  Life Sci       Date:  2021-04-15       Impact factor: 6.780

7.  Differences in clinical characteristics and liver injury between suspected and confirmed COVID-19 patients in Jingzhou, Hubei Province of China.

Authors:  Qing Zhang; Jie Li; Yan Zhang; Jie Gao; Peixue Wang; Minghua Ai; Wen Ding; Xiaoping Tan
Journal:  Medicine (Baltimore)       Date:  2021-05-14       Impact factor: 1.889

Review 8.  Humoral immune mechanisms involved in protective and pathological immunity during COVID-19.

Authors:  Gunawan Widjaja; Abduladheem Turki Jalil; Heshu Sulaiman Rahman; Walid Kamal Abdelbasset; Dmitry O Bokov; Wanich Suksatan; Mahnaz Ghaebi; Faroogh Marofi; Jamshid Gholizadeh Navashenaq; Farhad Jadidi-Niaragh; Majid Ahmadi
Journal:  Hum Immunol       Date:  2021-07-01       Impact factor: 2.850

Review 9.  Preventing the development of severe COVID-19 by modifying immunothrombosis.

Authors:  Gerwyn Morris; Chiara C Bortolasci; Basant K Puri; Lisa Olive; Wolfgang Marx; Adrienne O'Neil; Eugene Athan; Andre Carvalho; Michael Maes; Ken Walder; Michael Berk
Journal:  Life Sci       Date:  2020-10-20       Impact factor: 5.037

Review 10.  Can endolysosomal deacidification and inhibition of autophagy prevent severe COVID-19?

Authors:  Gerwyn Morris; Eugene Athan; Ken Walder; Chiara C Bortolasci; Adrienne O'Neil; Wolf Marx; Michael Berk; André F Carvalho; Michael Maes; Basant K Puri
Journal:  Life Sci       Date:  2020-10-06       Impact factor: 6.780
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.